Stories about research and scientific development at Mount Sinai
Pandemic’s Toll on Mount Sinai Front-Line Staff Is Surveyed, and Addressed
Front-line staff who were already feeling burnout showed the most signs of mental distress during the height of the COVID-19 pandemic, while those who fared best had an active social network and felt supported by their supervisors. These were among the many lessons...
Mount Sinai Creates COVID-19 Vaccine for Low- and Middle-lncome Countries
The development of a safe, effective, and inexpensive COVID-19 vaccine that can easily be produced and distributed in low- and middle-income countries is underway at the Icahn School of Medicine at Mount Sinai, where early phase 1 clinical testing in Vietnam and...
Improving Diversity in Autism Genomic Research
Genomic research is now an integral part of the study and treatment of autism spectrum disorder (ASD) and related neurodevelopmental disabilities, so it is crucial to include more ethnically and racially diverse populations, said Pilar Trelles, MD, a psychiatrist and...
A Major Breakthrough and Potential New Treatment for Children With an Inflammatory Blood Disease
A 17-year quest to understand Langerhans-cell histiocytosis (LCH)—an inflammatory blood disease that mostly affects children and can result in dementia and death—has led researchers at the Icahn School of Medicine at Mount Sinai and their colleagues in Texas to a...
Mount Sinai Establishes the First Link Between Ultrafine Air Pollutants and Asthma in Children
The link between prenatal exposure to ultrafine particles in air pollution and the development of asthma in preschool-age children has been established for the first time in the United States by a team of scientists led by Rosalind J. Wright, MD, MPH, Dean for...
Mount Sinai Awarded $42 Million to Prepare for Future Pandemics and Advance Influenza Research
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded the Icahn School of Medicine at Mount Sinai a seven-year contract valued at more than $42 million to advance basic research into influenza and COVID-19, and prepare for future pandemics....
COVID-19 Research Roundtable
Almost exactly one year ago, New York City faced the outbreak and first peak of the pandemic, and the city accounted for 25 percent of COVID-19 deaths in the United States. Mount Sinai Health System and health care workers responded to an unprecedented surge of...
Scientists Celebrate International Day of Immunology and Their Role in Advancing Breakthroughs for COVID-19
The significant role the human immune system has played in the spread and containment of the SARS-CoV-2 virus, which causes COVID-19, was the subject of an International Day of Immunology summit, held virtually on Thursday, April 29, 2021, and co-organized by...
Thousands of Mothers Take Part in Mount Sinai Study of COVID-19 and Pregnancy
A multidisciplinary team at Mount Sinai is conducting the first large-scale prospective study to examine the impact of COVID-19 infection during pregnancy on maternal and child outcomes. The study is funded by a $1.8 million contract from the Centers for Disease...